Licensing opportunities

Many of our laboratories have pioneered new technologies that are open to licensing and or co-development.

  • Small molecule treatment of multiple myeloma
  • Perforin inhibitors for allogeneic stem cell transplantation
  • Polygen – a breast cancer genetic risk reporting system
  • Humanised anti-RYK monoclonal antibody blocks Wnt signalling